Abstract:BackgroundDystrophin (DMD) gene mutations can affect muscular dystrophin isoform expression and result in progressive muscular dystrophy including Duchenne and Becker muscular dystrophies (DMD and BMD). To establish the correlation between phenotype and genotype and exemplify the current and future treatment for muscular dystrophy disorders, we investigated 20 patients suffering from a dystrophinopathy and summarized clinical manifestation and gene mutations of them. MethodsThe clinical manifestations, physical examination, laboratory work, and gene mutation results were collected in 20 patients with DMD or BMD diagnosed by clinical phenotype and genetic sequencing from July 2015 to December 2019. Multiplex ligation probe amplification (MLPA) and next-generation sequencing (NGS) were used to detect mutations in the DMD gene, and detected mutations were confirmed by Sanger sequencing. ResultsThe clinical manifestation of patients was characterized by progressive symmetrical muscle degeneration, limb weakness, and pseudohypertrophy along with the elevated concentration of creatine kinase, alanine aminotransferase, and aspartate aminotransferase. We found 11 dystrophin gene deletions (55%) and 4 duplication mutations (20%) among the affected patients. However, we also found point mutations including 1 nonsense (20%), 3 frameshifts (60%), and 1 splice sites (20%) mutations in the rest 5 patients. Among the 15 cases of exon deletion or duplication mutations, 7 were inherited from the mother, 3 were de-novo, while the other 5 were not tested. Besides, all 5 point-mutation cases were inherited from the mother, among which 4 point mutations were identified for the first time and linked to the disease phenotype. ConclusionsWe provided clinical portraits, genetic results, and the molecular effects of mutations in patients. Four novel point mutations were identified for the first time and associated with the development of DMD and BMD. Further, we expanded knowledge of the DMD variant spectrum and exemplified the emerging therapies in muscular dystrophy.

Symptoms and pathogenesis of manifesting carriers of Duchenne/Becker muscular dystrophy

Clinical, Myopathological and Genetic Features in Five Female Manifesting Carriers of Duchenne Muscular Dystrophy

Advances in the Pathogenic Research of Female Carriers with Symptomatic Duchenne Muscular Dystrophy

Clinical, pathological, and genetic characterization in a large Chinese cohort with female dystrophinopathy

Research Progress on Disease Models and Gene Therapy of Duchenne Muscular Dystrophy

Population-Wide Duchenne Muscular Dystrophy Carrier Detection by CK and Molecular Testing

A De Novo Mutation in Dystrophin Causing Muscular Dystrophy in a Female Patient.

[Carrier screening model for Duchenne muscular dystrophy for women of reproductive age based on a pre-pregnancy birth defect control platform].

An Ultra-Rare Manifestation of an X-Linked Recessive Disorder: Duchenne Muscular Dystrophy in a Female Patient

X-chromosome Inactivation Pattern of Amniocytes Predicts the Risk of Dystrophinopathy in Fetal Carriers of DMD Mutations.

Targeted Next-Generation Sequencing As a Comprehensive Test for Patients with and Female Carriers of DMD/BMD: a Multi-Population Diagnostic Study

Duchenne muscular dystrophy: pathogenesis and promising therapies

Genetic Variation Analysis and Treatment Strategy of 20 Patients with Dystrophin Gene Mutations

Cardiomyopathies Caused by Pathogenic Variants in the DMD Gene

DMD deletions underlining mild dystrophinopathies: literature review highlights phenotype-related mutation clusters and provides insights about genetic mechanisms and prognosis

Duchenne muscular dystrophy

Identify female carriers and de novo mutations in deletional Duchenne/Becker muscular dystrophy families.

Comprehensive Genetic Diagnosis of Patients with Duchenne/Becker Muscular Dystrophy (DMD/BMD) and Pathogenicity Analysis of Splice Site Variants in the DMD Gene

Duchenne Muscular Dystrophy and Dilated Cardiomyopathy with Deletion of Exon 45 and 49

Electrophysiologic and cardiovascular manifestations of Duchenne and Becker muscular dystrophies

[Genotype, Phenotype Analysis and Follow-Up Study on Patients with Duchenne/Becker Muscular Dystrophy].